Skip to content

Comparison of different methods for measuring the nutritional status and the identification of malnutrition in patients with hematological and oncological diseases

Comparison of different methods for measuring the nutritional status and the identification of malnutrition in patients with hematological and oncological diseases - MEPO-Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005597
Enrollment
50
Registered
2014-02-17
Start date
2012-08-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-D48 D50-D90

Interventions

Group 1: The nutritional status of hematological and oncological patients will be assessed by bioimpedance analysis, Nutritional Risk Screening and laboratory parameters such as albumin, prealbumin an

Sponsors

Universitätsklinikum Halle (Saale)Klinik für Innere Medizin IVHämatologie und Onkologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who were hospitalized for the beginning or the continuation of chemotherapy, older than 18 years, patient should be able to understand and to answer the complete questionnaire, signed and dated consent form, patient should be able to give its consent

Exclusion criteria

Exclusion criteria: Patients with known drug or alcohol dependency; patients with severe active infection; patients with severe chronic or infectious diseases (liver cirrhosis, hepatitis, rheumatism); abnormal laboratory values (ASAT >2,5x upper limit, ALAT >2,5x upper limit, creatinin >1,5x upper limit), patients with cardiac pacemaker, patients with heart defibrillator, patients with HIV/AIDS, patients with arm- or leg amputations, patients who receive parenteral nutrition, patients under dialysis treatment, patients with an impaired thyroid metabolism, patients where an exact height and weight determination is not possible

Design outcomes

Primary

MeasureTime frame
Comparability of the methods used with regard to the detection of nutritional status and the identification of malnutrition in patients with hematologic and oncologic diseases.

Secondary

MeasureTime frame
Applicability of the methods in the clinical setting.

Countries

Germany

Contacts

Public ContactJörn Rüssel

Universitätsklinikum Halle (Saale)Klinik für Innere Medizin IVHämatologie und Onkologie

joern.ruessel@uk-halle.de0345 557 2019

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026